HIT Health In Tech

NASDAQ
$0.40

Health In Tech (HIT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus HIT's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
1
2 transactions
Purchases
$0
0 shares
Sales
$3.0K
5,000 shares
Net activity
-$3.0K
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $3.0K 2 transactions · 5,000 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $2.1K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Hasan Zain Syed Chief Growth Officer Sell 10b5-1 1,667 $0.55 $917 171,993 −1% of holding
Hasan Zain Syed Chief Growth Officer Sell 10b5-1 3,333 $0.62 $2.1K 173,660 −1.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.